Hughes, E.; Latham, S.; Kuss, B.; Grist, S.; Hall, R.; Khong, T.; Gorniak, M.; Spencer, A.; Tam, C.; Mulligan, S.;
et al. HAT-PCR Enables Sensitive Quantification of Minimal Residual Disease in Chronic Lymphocytic Leukemia and Myeloma. Int. J. Mol. Sci. 2025, 26, 7720.
https://doi.org/10.3390/ijms26167720
AMA Style
Hughes E, Latham S, Kuss B, Grist S, Hall R, Khong T, Gorniak M, Spencer A, Tam C, Mulligan S,
et al. HAT-PCR Enables Sensitive Quantification of Minimal Residual Disease in Chronic Lymphocytic Leukemia and Myeloma. International Journal of Molecular Sciences. 2025; 26(16):7720.
https://doi.org/10.3390/ijms26167720
Chicago/Turabian Style
Hughes, Elizabeth, Sue Latham, Bryone Kuss, Scott Grist, Rachel Hall, Tiffany Khong, Malgorzata Gorniak, Andrew Spencer, Constantine Tam, Stephen Mulligan,
and et al. 2025. "HAT-PCR Enables Sensitive Quantification of Minimal Residual Disease in Chronic Lymphocytic Leukemia and Myeloma" International Journal of Molecular Sciences 26, no. 16: 7720.
https://doi.org/10.3390/ijms26167720
APA Style
Hughes, E., Latham, S., Kuss, B., Grist, S., Hall, R., Khong, T., Gorniak, M., Spencer, A., Tam, C., Mulligan, S., Bailey, S., Sartor, M., Carney, D., Cull, G., Gottlieb, D., & Morley, A.
(2025). HAT-PCR Enables Sensitive Quantification of Minimal Residual Disease in Chronic Lymphocytic Leukemia and Myeloma. International Journal of Molecular Sciences, 26(16), 7720.
https://doi.org/10.3390/ijms26167720
